Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China · Delayed Price · Currency is CNY 13.56
-0.01 (-0.07%)
May 15, 2026, 10:35 AM CST
Shinva Medical Instrument Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 9,682 | 9,736 | 9,864 | 9,904 | 9,072 | 9,343 |
Other Revenue | - | - | 156.13 | 108 | 210.16 | 139.3 |
| 9,682 | 9,736 | 10,021 | 10,012 | 9,282 | 9,482 | |
Revenue Growth (YoY) | -1.20% | -2.84% | 0.09% | 7.87% | -2.11% | 3.62% |
Cost of Revenue | 7,228 | 7,288 | 7,461 | 7,394 | 6,863 | 7,200 |
Gross Profit | 2,455 | 2,448 | 2,559 | 2,618 | 2,419 | 2,282 |
Selling, General & Admin | 1,315 | 1,300 | 1,291 | 1,344 | 1,349 | 1,324 |
Research & Development | 423.08 | 442.03 | 436.08 | 443.37 | 401.27 | 295.98 |
Other Operating Expenses | 9.33 | 1.95 | 68.78 | 76.99 | 67.62 | 59.36 |
Operating Expenses | 1,749 | 1,744 | 1,865 | 1,948 | 1,846 | 1,714 |
Operating Income | 705.63 | 703.86 | 694.8 | 670.31 | 572.27 | 567.33 |
Interest Expense | - | - | -44.79 | -47.07 | -56.93 | -76.26 |
Interest & Investment Income | 27.21 | 39.1 | 95.57 | 110.96 | 61.75 | 126.94 |
Currency Exchange Gain (Loss) | - | - | 4.14 | 7.54 | 10.37 | -0.99 |
Other Non Operating Income (Expenses) | -74.28 | -72.34 | -21.91 | -9.44 | -4.17 | -12.03 |
EBT Excluding Unusual Items | 658.55 | 670.62 | 727.8 | 732.3 | 583.29 | 604.99 |
Impairment of Goodwill | - | - | -15.22 | -11.49 | - | - |
Gain (Loss) on Sale of Investments | -23.76 | - | - | 12.54 | -57.21 | 60.71 |
Gain (Loss) on Sale of Assets | 0.07 | -0.99 | -1.51 | 4.4 | 0.48 | -0.35 |
Asset Writedown | -84.59 | -78.5 | - | -0.73 | - | -0.62 |
Legal Settlements | - | - | - | - | - | -0.57 |
Other Unusual Items | - | - | 84.59 | 1.57 | 49.53 | 53.87 |
Pretax Income | 550.28 | 591.12 | 795.66 | 738.58 | 576.09 | 718.03 |
Income Tax Expense | 58.7 | 62.99 | 103.76 | 62.08 | 49.18 | 162.01 |
Earnings From Continuing Operations | 491.58 | 528.13 | 691.9 | 676.5 | 526.91 | 556.02 |
Minority Interest in Earnings | -1.64 | -1.8 | -0.29 | -22.5 | -26.84 | 0.47 |
Net Income | 489.94 | 526.34 | 691.61 | 654 | 500.07 | 556.49 |
Net Income to Common | 489.94 | 526.34 | 691.61 | 654 | 500.07 | 556.49 |
Net Income Growth | -23.57% | -23.90% | 5.75% | 30.78% | -10.14% | 137.68% |
Shares Outstanding (Basic) | 611 | 605 | 607 | 595 | 529 | 528 |
Shares Outstanding (Diluted) | 611 | 605 | 607 | 600 | 529 | 528 |
Shares Change (YoY) | 1.16% | -0.28% | 1.11% | 13.53% | 0.08% | 0.64% |
EPS (Basic) | 0.80 | 0.87 | 1.14 | 1.10 | 0.95 | 1.05 |
EPS (Diluted) | 0.80 | 0.87 | 1.14 | 1.09 | 0.95 | 1.05 |
EPS Growth | -24.44% | -23.68% | 4.59% | 15.20% | -10.21% | 136.17% |
Free Cash Flow | 702.87 | 319.09 | 29.85 | 494.34 | 140.47 | 1,128 |
Free Cash Flow Per Share | 1.15 | 0.53 | 0.05 | 0.82 | 0.27 | 2.14 |
Dividend Per Share | - | - | 0.250 | 0.385 | 0.115 | 0.115 |
Dividend Growth | - | - | -35.00% | 233.28% | - | 50.07% |
Gross Margin | 25.35% | 25.15% | 25.54% | 26.15% | 26.06% | 24.06% |
Operating Margin | 7.29% | 7.23% | 6.93% | 6.69% | 6.17% | 5.98% |
Profit Margin | 5.06% | 5.41% | 6.90% | 6.53% | 5.39% | 5.87% |
Free Cash Flow Margin | 7.26% | 3.28% | 0.30% | 4.94% | 1.51% | 11.90% |
EBITDA | 925.12 | 916.63 | 880.63 | 857.33 | 761.5 | 744.07 |
EBITDA Margin | 9.55% | 9.41% | 8.79% | 8.56% | 8.20% | 7.85% |
D&A For EBITDA | 219.5 | 212.77 | 185.84 | 187.03 | 189.23 | 176.74 |
EBIT | 705.63 | 703.86 | 694.8 | 670.31 | 572.27 | 567.33 |
EBIT Margin | 7.29% | 7.23% | 6.93% | 6.69% | 6.17% | 5.98% |
Effective Tax Rate | 10.67% | 10.66% | 13.04% | 8.40% | 8.54% | 22.56% |
Revenue as Reported | - | - | 10,021 | 10,012 | 9,282 | 9,482 |
Advertising Expenses | - | - | 20.65 | 24.19 | 22.66 | 38.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.